RC48-ADC in Combination With Gemcitabine in High Risk NMIBC Subjects

NCT05943379 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

85

Enrollment

INDUSTRY

Sponsor class

Conditions

NMIBC

Interventions

DRUG: RC48-ADC in Combination with gemcitabine

Sponsor

RemeGen Co., Ltd.